Please use this identifier to cite or link to this item:
Title: Botulinum toxin type A in the treatment of Raynaud's phenomenon: A three-year follow-up study.
Issue Date: Dec-2018
Citation: Eur J Rheumatol.2018 Dec;(5)4:224-229
Abstract: Raynaud's phenomenon consists of vasospastic disease of the digital arteries after exposure to cold or stress. It causes an important reduction in the patient's quality of life when severe. The available treatments do not always offer favorable results.
PMID: 30501848
Rights: openAccess
ISSN: 2147-9720
Appears in Collections:Hospitales > H. U. Sureste > Artículos
Fundaciones e Institutos de Investigación > FIB H. U. Príncipe de Asturias > Artículos

Files in This Item:
File Description SizeFormat 
PMC6267752.pdf1.36 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.